HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William Pao Selected Research

Cholangiocarcinoma

12/2014Anchored multiplex PCR for targeted next-generation sequencing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William Pao Research Topics

Disease

106Neoplasms (Cancer)
04/2024 - 07/2003
66Lung Neoplasms (Lung Cancer)
01/2018 - 09/2004
46Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 02/2004
46Adenocarcinoma of Lung
10/2016 - 01/2005
9Disease Progression
01/2018 - 02/2006
9Adenocarcinoma
11/2013 - 03/2004
7Melanoma (Melanoma, Malignant)
01/2016 - 01/2012
4Carcinogenesis
06/2012 - 09/2003
3Exanthema (Rash)
01/2018 - 04/2011
3Fatigue
01/2018 - 04/2011
3Colorectal Neoplasms (Colorectal Cancer)
04/2015 - 09/2003
3Colonic Neoplasms (Colon Cancer)
07/2012 - 09/2003
3Sarcoma (Soft Tissue Sarcoma)
01/2012 - 07/2003
3Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)
05/2011 - 06/2006
2Diarrhea
01/2018 - 11/2017
2Brain Neoplasms (Brain Tumor)
01/2018 - 11/2005
2Glioblastoma (Glioblastoma Multiforme)
12/2014 - 06/2009
2Thyroid Neoplasms (Thyroid Cancer)
12/2014 - 11/2010
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2013 - 06/2011
2Leukemia
01/2012 - 11/2010
2Neoplasm Metastasis (Metastasis)
12/2011 - 09/2010
2Breast Neoplasms (Breast Cancer)
11/2011 - 03/2011
2Glioma (Gliomas)
11/2011 - 11/2005
1Nausea
01/2018
1Paronychia
11/2017
1Urinary Bladder Neoplasms (Bladder Cancer)
12/2015
1Ear Neoplasms
05/2015
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2015
1Cholangiocarcinoma
12/2014
1Clinical Deterioration
06/2014
1Adenosquamous Carcinoma
11/2013

Drug/Important Bio-Agent (IBA)

64ErbB Receptors (EGF Receptor)IBA
01/2018 - 02/2004
48Tyrosine Kinase InhibitorsIBA
01/2018 - 03/2005
45Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018 - 09/2004
40Gefitinib (Iressa)FDA Link
11/2017 - 02/2004
32Phosphotransferases (Kinase)IBA
01/2016 - 09/2004
17Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2014 - 02/2004
15DNA (Deoxyribonucleic Acid)IBA
07/2015 - 08/2005
7Cetuximab (Erbitux)FDA Link
11/2017 - 10/2009
7AfatinibIBA
11/2017 - 10/2012
7Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2015 - 11/2008
7Proteins (Proteins, Gene)FDA Link
07/2011 - 09/2003
6Anaplastic Lymphoma KinaseIBA
09/2014 - 12/2010
6Biomarkers (Surrogate Marker)IBA
11/2011 - 06/2008
5osimertinibIBA
10/2022 - 09/2014
4CrizotinibIBA
09/2014 - 12/2011
4Tyrosine (L-Tyrosine)FDA Link
01/2012 - 12/2007
4Threonine (L-Threonine)FDA Link
11/2008 - 03/2005
3Peptides (Polypeptides)IBA
01/2017 - 05/2011
3NucleotidesIBA
07/2015 - 09/2012
3Imatinib Mesylate (Gleevec)FDA Link
01/2015 - 08/2005
3EverolimusFDA Link
10/2010 - 08/2007
3tyrosine receptor (receptor, tyrosine)IBA
10/2009 - 11/2008
3Methionine (L-Methionine)FDA Link
12/2007 - 03/2005
2AgarIBA
01/2017 - 01/2014
2rociletinibIBA
10/2016 - 12/2013
2Guanine NucleotidesIBA
01/2016 - 07/2014
2Carrier Proteins (Binding Protein)IBA
01/2016 - 07/2014
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2015 - 06/2009
2Mitogen-Activated Protein KinasesIBA
09/2015 - 11/2008
2RNA (Ribonucleic Acid)IBA
07/2015 - 12/2013
2TOR Serine-Threonine KinasesIBA
06/2014 - 10/2010
2Lapatinib (GW572016)FDA Link
03/2011 - 08/2005
2CarcinogensIBA
06/2010 - 09/2009
2Cisplatin (Platino)FDA LinkGeneric
12/2009 - 01/2008
2Oncogene Proteins (Oncogene Protein)IBA
10/2009 - 09/2003
2GTP Phosphohydrolases (GTPases)IBA
11/2006 - 01/2005
2Doxycycline (Periostat)FDA LinkGeneric
06/2006 - 07/2003
1AntibodiesIBA
04/2024
1Membrane Proteins (Integral Membrane Proteins)IBA
04/2024
1Alanine Transaminase (SGPT)IBA
01/2018
1Cancer VaccinesIBA
01/2017
1HLA-A Antigens (HLA-A)IBA
01/2017
1CateninsIBA
01/2017
1CytokinesIBA
03/2016
1Janus KinasesIBA
03/2016
1ALW-II-41-27IBA
01/2016
1GTP-Binding Proteins (G-Protein)IBA
01/2016
1cyclo(Arg-Pro) (CI 4)IBA
12/2015
1AmphiregulinIBA
09/2015
1LigandsIBA
09/2015
1trametinibIBA
09/2015
1AZD 6244IBA
06/2015
1Adenosine Monophosphate (AMP)IBA
12/2014
1Insulin-Like PeptidesIBA
09/2014
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
08/2014
1Sirolimus (Rapamycin)FDA Link
06/2014
1MTOR InhibitorsIBA
06/2014
1Mechanistic Target of Rapamycin Complex 1IBA
05/2014
1human PMS2 proteinIBA
01/2014
1Coal (Coals)IBA
11/2013
1Epidermal Growth Factor (EGF)IBA
09/2013

Therapy/Procedure

54Therapeutics
04/2024 - 03/2005
12Drug Therapy (Chemotherapy)
12/2014 - 01/2005
3Aftercare (After-Treatment)
10/2016 - 03/2008
2Radiotherapy
04/2024 - 12/2014
2Immunotherapy
01/2018 - 01/2017
2Precision Medicine
01/2018 - 05/2011
2Adjuvant Chemotherapy
04/2009 - 01/2008
1Oral Administration
12/2013